Answers are grounded in this paper and cite their sources.
Successes in CAR T cell translation have propelled their commercial launch, but expanding the impact of cancer immunotherapies remains challenging. Successes in CAR T cell translation have propelled their commercial launch, but expanding the impact of cancer immunotherapies remains challenging.
No takes yet. Share an insight, caveat, or question.
Schultz et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: